Fresenius gets warned after FDA inspection

The FDA has sent a warning letter to Fresenius Medical Care Holdings that states its facilities used to produce kidney dialysis devices don't conform to agency standards. The FDA said the findings in the letter followed an inspection of the Waltham, MA-based company's plant between June 15 and August 6, 2010. Warning letter | Report

Suggested Articles

Philips looked back on 15 years of data from one of its telehealth-equipped intensive care units, where centralizing operations reduced mortality.

Sanofi will look to pull back from its three-year-old relationship with Verily and their virtual diabetes clinic, Onduo.

AstraZeneca is linking up with DeepMatter, a big data firm focused on achieving reproducibility in chemistry, to help improve its compound synthesis.